查找临床试验
已按「血管炎」检索，对应国际通用词 vasculitis
共找到 56 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:25，每 5 分钟自动同步A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
China
年龄 18 Years – 65 Years
China Immunotech (Beijing) Biotechnology Co., Ltd.
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
China
年龄 18 Years – 65 Years
Peking University People's Hospital
A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
China
年龄 18 Years – 65 Years
Beijing GoBroad Hospital
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
China
年龄 18 Years – 不限
Institute of Hematology & Blood Diseases Hospital, China
Baricitinib in the Treatment of Intestinal Behçet's Syndrome
China
年龄 18 Years – 65 Years
Peking Union Medical College Hospital
Study of Ravulizumab in Pediatric Participants With Primary IgAN
United States、China、Italy、Japan、South Korea 等 7 国
年龄 2 Years – 18 Years
Alexion Pharmaceuticals, Inc.
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
China
年龄 18 Years – 65 Years
China Immunotech (Beijing) Biotechnology Co., Ltd.
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
China
年龄 18 Years – 80 Years
Peking University Third Hospital
A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）
China
年龄 18 Years – 不限
Guangdong Hengrui Pharmaceutical Co., Ltd
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
China
年龄 1 Month – 18 Years
Children's Hospital of Fudan University
Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) Vasculitis
United States、China
年龄 不限 – 不限
Qifeng Zhang
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
China
年龄 2 Years – 18 Years
Children's Hospital of Fudan University